BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy, focusing on innovative immuno-oncology drug candidates
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy, focusing on innovative immuno-oncology drug candidates.
The top three firms on F4's Biotech & Life Sciences investor list.